These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 7945521)

  • 41. Convenient one pot synthesis of some novel derivatives of thiazolo[2,3-b]dihydropyrimidinone possessing 4-methylthiophenyl moiety and evaluation of their antibacterial and antifungal activities.
    Ashok M; Holla BS; Kumari NS
    Eur J Med Chem; 2007 Mar; 42(3):380-5. PubMed ID: 17070617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sesquiterpenes and other constituents from Achillea wilsoniana.
    Yang M; Li JX; Li X; Jia ZJ
    Pharmazie; 2005 Jul; 60(7):554-8. PubMed ID: 16076087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and structure-activity relationships of 2-vinylchroman-4-ones as potent antibiotic agents.
    Albrecht U; Lalk M; Langer P
    Bioorg Med Chem; 2005 Mar; 13(5):1531-6. PubMed ID: 15698769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Photodegradation products of levofloxacin in aqueous solution.
    Yoshida Y; Sato E; Moroi R
    Arzneimittelforschung; 1993 May; 43(5):601-6. PubMed ID: 8329007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mycinamicins, new macrolide antibiotics. XIII. Isolation and structures of novel fermentation products from Micromonospora griseorubida (FERM BP-705).
    Kinoshita K; Takenaka S; Suzuki H; Morohoshi T; Hayashi M
    J Antibiot (Tokyo); 1992 Jan; 45(1):1-9. PubMed ID: 1548179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
    Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
    Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physico-chemical properties and biological activities of erythromycin nalidixate.
    Goswami BB; Manna PK; Basu SK
    Arzneimittelforschung; 1995 Jul; 45(7):813-4. PubMed ID: 8573228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies of erythromycin maltobionate, a new derivative of erythromycin.
    Manna PK; Basu SK
    Drug Dev Ind Pharm; 1999 Mar; 25(3):391-5. PubMed ID: 10071836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analytical and chemical profile of pidotimod.
    Crimella T; Orlandi R; Bocchiola G; Anders U; Stradi R
    Arzneimittelforschung; 1994 Dec; 44(12A):1405-10. PubMed ID: 7857332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative study of pharmacokinetic parameters between clarithromycin and erythromycin stearate in relation to their physicochemical properties.
    Ishii K; Saito Y; Itai S; Nemoto M; Takayama K; Nagai T
    Drug Dev Ind Pharm; 1998 Feb; 24(2):129-37. PubMed ID: 15605442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of HPLC/MS, GC/MS, NMR, UV and IR to identify a degradation product of eperisone hydrochloride in the tablets.
    Ding L; Wang X; Yang Z; Chen Y
    J Pharm Biomed Anal; 2008 Jan; 46(2):282-7. PubMed ID: 18023316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study of erythromycin A decomposition products in aqueous solution by solid-phase microextraction/liquid chromatography/tandem mass spectrometry.
    Volmer DA; Hui JP
    Rapid Commun Mass Spectrom; 1998; 12(3):123-9. PubMed ID: 9474800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of macrolide antibiotics by liquid chromatography.
    González de la Huebra MJ; Vincent U
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):376-98. PubMed ID: 15963675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antimicrobial activity of arylazoenamines.
    Canu Boido C; Boido V; Sparatore F; Sparatore A; Bombieri G; Benetollo F; Debbia E; Pesce Schito A
    Farmaco; 1993 Jun; 48(6):749-75. PubMed ID: 8373502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Levels of flurithromycin in female genital tissue.
    Furneri PM; Cianci A; Campo L; Roccasalva LS; Tempera G; Fiore G; Palumbo G; Lepore AM; Nicoletti G
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1899-901. PubMed ID: 7486945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and analytical profile of the new potent antibronchospastic agent 7-[(2,2-dimethyl)propyl]-1-methyl xanthine.
    Agostini O; Bonacchi G; Coppini G; Di Marco G; Paoli P; Toja E
    Arzneimittelforschung; 1995 Jun; 45(6):684-8. PubMed ID: 7646571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-Didemethyl-n-propionyl-6,9;9, 12-erythromycin A-spiroketal, a new metabolite of erythromycin ethyl succinate in man.
    Majer J; Stanaszek RS; Mueller SL; Marti G
    Drug Metab Dispos; 1978; 6(6):673-6. PubMed ID: 33030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic fate of Zolimidine. II. Analytical profile, tissue levels and urinary excretion in animals and in man.
    Picco S; Bonaldi A; Frigerio A; Danieli B; Almirante L
    Farmaco Sci; 1974 Nov; 29(11):848-60. PubMed ID: 4442573
    [No Abstract]   [Full Text] [Related]  

  • 59. Physico-chemical properties of the new antibronchospastic agent isbufylline.
    Agostini O; Bonacchi G; Dapporto P; Paoli P; Fedi M; Manzini S
    Arzneimittelforschung; 1990 Oct; 40(10):1089-92. PubMed ID: 1705424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antibiotics of an aromatic nature from Pseudomonas cepacia].
    Smirnov VV; Kiprianova EA; Dodatko TA; Garagulia AD; Kliuev NA
    Mikrobiol Zh (1978); 1991; 53(5):41-5. PubMed ID: 1724281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.